Lapierre Y D, Butter H J, Oyewumi L K
Neuropsychobiology. 1983;9(2-3):88-93. doi: 10.1159/000117943.
The present investigation assessed 45 anxious neurotic adult patients treated double-blindly in three randomized drug groups; bromazepam, diazepam and placebo. Non-signal, simple and complex signal stimuli were presented to monitor electrodermal activity changes at baseline, 4 h, 1 week and 14 days of treatment. The results indicate that patients with generalized anxiety disorder treated with bromazepam developed decreased skin conductance during the presentation of visual, auditory, and tactile stimuli presentations. Such skin conductance changes were not significant for patients on diazepam and placebo. Future clinical and research implications of these perceptual and psychophysiological results are discussed in conjunction with the usage of a functional-realistic-instrumental paradigm rather than studying anxiety on an attentional-arousal continuum.
本研究评估了45名焦虑神经症成年患者,他们被随机分为三个双盲药物治疗组,分别使用溴西泮、地西泮和安慰剂。在治疗的基线、4小时、1周和14天时,呈现非信号、简单信号和复杂信号刺激,以监测皮肤电活动的变化。结果表明,用溴西泮治疗的广泛性焦虑症患者在视觉、听觉和触觉刺激呈现期间皮肤电导降低。地西泮和安慰剂组患者的这种皮肤电导变化不显著。结合功能现实工具范式的使用,而非在注意力-唤醒连续体上研究焦虑,讨论了这些感知和心理生理结果对未来临床和研究的意义。